Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|May 1, 1977
Phase II study of pyrazofurin in advanced colorectal carcinomaE T Creagan, J Rubin, C G Moertel, et al.
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Cancer|August 1, 1995
Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancerJ A Bonner, R T Eagan, V Liengswangwong, et al.
American Journal of Clinical Oncology|April 1, 1996
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancerS Frytak, E G Shaw, J R Jett, et al.
Cancer|November 1, 1992
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancerC M van Haelst-Pisani, R L Richardson, J Su, et al.
Cancer|March 15, 1995
Prophylactic cranial irradiation in limited-stage small cell lung cancerV Liengswangwong, J A Bonner, E G Shaw, et al.
American Journal of Clinical Oncology|February 1, 1989
Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiationS Frytak, J N Shaw, B P O'Neill, et al.
Cancer Investigation|January 1, 1988
Treatment toxicities in long-term survivors of limited small cell lung cancerS Frytak, J N Shaw, R E Lee, et al.
Cancer Clinical Trials|January 1, 1981
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|May 1, 1977
Phase II study of pyrazofurin in advanced colorectal carcinomaE T Creagan, J Rubin, C G Moertel, et al.
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Cancer|August 1, 1995
Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancerJ A Bonner, R T Eagan, V Liengswangwong, et al.
American Journal of Clinical Oncology|April 1, 1996
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancerS Frytak, E G Shaw, J R Jett, et al.
Cancer|November 1, 1992
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancerC M van Haelst-Pisani, R L Richardson, J Su, et al.
Cancer|March 15, 1995
Prophylactic cranial irradiation in limited-stage small cell lung cancerV Liengswangwong, J A Bonner, E G Shaw, et al.
American Journal of Clinical Oncology|February 1, 1989
Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiationS Frytak, J N Shaw, B P O'Neill, et al.
Cancer Investigation|January 1, 1988
Treatment toxicities in long-term survivors of limited small cell lung cancerS Frytak, J N Shaw, R E Lee, et al.
Cancer Clinical Trials|January 1, 1981
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Pageof 11